Given the known crucial role of RAS signaling in CRC and the novel mechanism of PTP1B in regulating p120RasGAP that we have characterized in the current project, we were interested to know whether targeting PTP1B exerts therapeutic potential against CRC. The gene discussed is RASA1; the disease is colorectal carcinoma.